SNTI - Senti Biosciences, Inc.

0.9649
0.027   2.777%

Share volume: 150,605
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.19%

PREVIOUS CLOSE
CHG
CHG%
$0.94
0.03
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
39%
Profitability 35%
Dept financing 35%
Liquidity 58%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.65%
1 Month
6.21%
3 Months
-59.63%
6 Months
-26.90%
1 Year
-72.59%
2 Year
139.73%
Key data
Stock price
$0.96
P/E Ratio 
0.00
DAY RANGE
$0.91 - $0.98
EPS 
-$4.68
52 WEEK RANGE
$0.80 - $5.10
52 WEEK CHANGE
-$72.19
MARKET CAP 
36.886 M
YIELD 
N/A
SHARES OUTSTANDING 
26.291 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
3.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$122,855
AVERAGE 30 VOLUME 
$153,421
Company detail
CEO: Timothy K. Lu
Region: US
Website: sentibio.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Dynamics Special Purpose Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination. The company was incorporated in 2021 and is based in Redwood City, California.

Recent news